INABILITY OF CYTOMEGALOVIRUS-INFECTION OF CULTURED ENDOTHELIAL-CELLS TO INDUCE HLA CLASS-II ANTIGEN EXPRESSION

被引:47
|
作者
SEDMAK, DD
ROBERTS, WH
STEPHENS, RE
BUESCHING, WJ
MORGAN, LA
DAVIS, DH
WALDMAN, WJ
机构
[1] The Department of Pathology, The Ohio State University College of Medicine, Columbus, OH
关键词
D O I
10.1097/00007890-199002000-00043
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytomegalovirus infection in the renal allograft recipient has been associated with the initiation of acute rejection. The mechanism of this induction is unknown. It may be related to renal tubular epithelial and endothelial expression of HLA class II antigens or a CMV immediate-early antigen that exhibits immunologic crossreactivity with HLA DR. In this study the ability of CMV to both infect and subsequently induce class II antigen expression on cultured human umbilical-vein endothelial cells (HUVEs), in the absence of cytokines, particularly gamma interferon, was tested. Individual HUVE cell lines were first proven to express HLA class II antigens in the presence of 10, 100, and 200 units of recombinant IFN-ɣ as early as 24 hr postincubation by an immunohistochemical technique and by flow cytometry. These cell lines were successfully infected with CMV strains AD 169 and CMV3 as determined by the presence of early and late viral antigens and CMV DNA. The degree of infection was dose and incubation-time dependent. Infection of HUVEs with these CMV strains and a nonattenuated clinical isolate failed to induce HLA DR, DP, or DQwl expression in the absence of IFN-ɣ. These findings support the hypothesis that endothelial cells in vivo may serve as reservoirs of CMV infection. They do not support the hypothesis that CMV produces an immediate-early antigen that has immunologic crossreactivity with HLA DR. Furthermore, there is no support for the hypothesis that CMV independently induces HLA class II antigens in the absence of IFN-ɣ. © 1990 by Williams & Wilkins.
引用
收藏
页码:458 / 462
页数:5
相关论文
共 50 条
  • [21] CYTOMEGALOVIRUS DOWN-REGULATES HLA CLASS-II ANTIGEN EXPRESSION ON INFECTED ALVEOLAR EPITHELIAL-CELLS
    SINCO, CN
    KNIGHT, D
    SEDMAK, D
    LABORATORY INVESTIGATION, 1992, 66 (01) : A93 - A93
  • [22] IN-VITRO INDUCTION OF ENDOTHELIAL HLA CLASS-II ANTIGEN EXPRESSION BY CYTOMEGALOVIRUS-ACTIVATED CD4(+) T-CELLS
    WALDMAN, WJ
    KNIGHT, DA
    ADAMS, PW
    OROSZ, CG
    SEDMAK, DD
    TRANSPLANTATION, 1993, 56 (06) : 1504 - 1512
  • [23] EFFECT OF METHYLATION ON THE EXPRESSION OF HLA CLASS-II ANTIGEN
    ONEILL, L
    LEE, JS
    HUMAN IMMUNOLOGY, 1986, 17 (02) : 124 - 124
  • [24] HETEROGENEITY OF RENAL ENDOTHELIAL-CELLS FOR CLASS-II ANTIGENS
    MACIVER, AG
    TRICKETT, LP
    EVANS, PR
    SMITH, JL
    SLAPAK, M
    JOURNAL OF PATHOLOGY, 1984, 143 (04): : A318 - A318
  • [25] DIRECT INDUCTION OF MHC CLASS-I, BUT NOT CLASS-II, EXPRESSION ON ENDOTHELIAL-CELLS BY CYTOMEGALO-VIRUS INFECTION
    VANDORP, WT
    JONGES, E
    BRUGGEMAN, CA
    DAHA, MR
    VANES, LA
    VANDERWOUDE, FJ
    TRANSPLANTATION, 1989, 48 (03) : 469 - 472
  • [26] IMMUNOCYTOCHEMICAL CHARACTERIZATION OF CLASS-II MHC ANTIGEN ON MURINE CEREBRAL CAPILLARY ENDOTHELIAL-CELLS
    HOGAN, RN
    MCCARRON, RM
    SPATZ, M
    MCFARLIN, DE
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1986, 45 (03): : 357 - 357
  • [27] REGULATION OF HLA CLASS-I AND CLASS-II ANTIGEN EXPRESSION
    CRESSWELL, P
    BRITISH MEDICAL BULLETIN, 1987, 43 (01) : 66 - 80
  • [28] REGULATION OF HLA CLASS-II ANTIGEN EXPRESSION ON CULTURED CORNEAL EPITHELIUM BY INTERFERON-GAMMA
    IWATA, M
    KIRITOSHI, A
    ROAT, MI
    YAGIHASHI, A
    THOFT, RA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (09) : 2714 - 2721
  • [29] CLASS-II ANTIGEN EXPRESSION ON RETINOBLASTOMA CELLS
    DETRICK, B
    CHAN, C
    RODRIGUES, M
    KYRITSIS, A
    CHADER, GJ
    HOOKS, JJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (06): : 321 - 321
  • [30] INTERFERON-GAMMA MODULATES HLA CLASS-II ANTIGEN EXPRESSION ON CULTURED HUMAN THYMIC EPITHELIAL-CELLS
    BERRIH, S
    ARENZANASEISDEDOS, F
    COHEN, S
    DEVOS, R
    CHARRON, D
    VIRELIZIER, JL
    JOURNAL OF IMMUNOLOGY, 1985, 135 (02): : 1165 - 1171